Benzinga | Oct 27, 2021 05:15AM EDT

SVB Leerink Maintains Market Perform on Myovant Sciences, Lowers Price Target to $23

SVB Leerink analyst Roanna Ruiz maintains Myovant Sciences (NYSE:MYOV) with a Market Perform and lowers the price target from $24 to $23.